Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New BRCA testing method could personalize ovarian cancer care

NCT ID NCT06274541

First seen Apr 18, 2026 · Last updated May 22, 2026 · Updated 9 times

Summary

This study looked at whether testing ovarian cancer tumors for BRCA gene mutations right in the doctor's office is practical and helpful. 200 patients with a specific type of ovarian cancer provided tumor samples for genetic testing. The goal was to see if this upfront testing could guide treatment decisions, like using targeted drugs, and improve genetic counseling for patients and their families.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FALLOPIAN TUBE CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Bon Secours

    Cork, Munster, Ireland

  • Cork University Hospital

    Cork, Munster, Ireland

  • Mater Misericordiae University Hospital / Mater Private Hospital

    Dublin, Leinster, Ireland

  • St James's Hospital

    Dublin, Leinster, Ireland

  • University Hospital Limerick

    Limerick, Munster, Ireland

Conditions

Explore the condition pages connected to this study.